Click a link below to view the mailing archive as if it had been sent to you.
| 2022-04-29 12:15 | | AstraZeneca plans new R&D hub in Kendall Square and more... |
| 2022-04-29 00:15 | | Merck makes $3.2bn from COVID-19 drug Lagevrio in Q1 and more... |
| 2022-04-28 12:15 | | Moderna seeks FDA clearance for COVID-19 vaccine in young children and more... |
| 2022-04-28 00:15 | | Boston Scientific surges 10% in Q1 amid slew of FDA nods, company reorganization and more... |
| 2022-04-27 12:15 | | ‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar and more... |
| 2022-04-27 00:15 | | Novartis confirms 'thousands' of layoffs loom as its global reorganization rolls ahead and more... |
| 2022-04-26 12:15 | | Sanofi taps McLaren to apply racing know-how to pharma manufacturing and more... |
| 2022-04-26 00:15 | | FDA approves first COVID treatment for children under 12 and more... |
| 2022-04-25 12:15 | | Roche’s oral SERD giredestrant fails breast cancer trial and more... |
| 2022-04-24 00:15 | | Thought CETP inhibition was dead? Think again and more... |
| 2022-04-22 12:15 | | Biogen pulls European application for Aduhelm in another setback for the Alzheimer's drug and more... |
| 2022-04-22 00:15 | | FDA's ODAC votes unanimously that future PI3K inhibitors should include randomized data for blood cancers and more... |
| 2022-04-21 12:15 | | Prescription drug use surged last year — but IQVIA doesn't expect that to last and more... |
| 2022-04-21 00:15 | | Abbott's Diversified Portfolio Is Its Secret Sauce and more... |
| 2022-04-20 12:15 | | AstraZeneca Pushes Deeper into CDx Space with New Collaboration and more... |
| 2022-04-20 00:15 | | Axsome and Aytu's Positive Day with the FDA and more... |
| 2022-04-19 12:15 | | Regeneron sees skin cancer potential beyond PD-1s with $250M Checkmate acquisition and more... |
| 2022-04-19 00:15 | | A potential target for Alzheimer's treatment? Researchers unearth new immune response pathway and more... |
| 2022-04-18 12:15 | | Biotech's top 10 money raisers of 2021 and more... |
| 2022-04-16 00:15 | | Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court and more... |
| 2022-04-14 12:15 | | Here’s How Pfizer Is Boldly Moving into Digital Health and more... |
| 2022-04-14 00:15 | | GSK to buy Sierra Oncology amid pressure to boost drug pipeline and more... |
| 2022-04-13 12:15 | | CMS official on Alzheimer's drug coverage decision: Don't read between the lines for other accelerated approvals and more... |
| 2022-04-13 00:15 | | Can digital therapeutics be profitable? and more... |
| 2022-04-12 12:15 | | Thousands of layoffs planned as part of Novartis restructuring — report and more... |
| 2022-04-12 00:15 | | Pfizer to drop $74M for COVID cough-screening smartphone app developer and more... |
| 2022-04-11 12:15 | | Seagen scores $41.8M in Enhertu patent case against Daiichi Sankyo and more... |
| 2022-04-11 00:15 | | AACR22: As post-Covid development takes shape, BioNTech reports first human data for CAR-T/cancer vaccine combo and more... |
| 2022-04-08 12:15 | | US Congress proposes bills to strengthen pharma competition, promote innovation and more... |
| 2022-04-08 00:15 | | CMS finalizes restrictions on Biogen's Alzheimer's drug coverage, will only fund use in clinical trials and more... |
| 2022-04-07 12:15 | | AstraZeneca bets $25M on preclinical bispecific against hot target, docking in Chinese Harbour to land global rights and more... |
| 2022-04-07 00:15 | | A Win for AI: FDA Approves BioXCel Therapy for Bipolar Disorder and Schizophrenia and more... |
| 2022-04-06 12:15 | | Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time and more... |
| 2022-04-06 00:15 | | Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021 and more... |
| 2022-04-05 12:15 | | Feeling Blue: bluebird bio cuts staff by 30%, prepares for FDA decision and more... |
| 2022-04-05 00:15 | | 'About as true as saying the earth is flat': Alzheimer's expert picks apart Biogen's Aduhelm manuscript and more... |
| 2022-04-04 12:15 | | In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs and more... |
| 2022-04-02 12:15 | | More biosimilar use could've saved Medicare and beneficiaries $84M in 2019, HHS OIG says and more... |
| 2022-04-01 12:15 | | Ken Frazier joins board of Eikon, which is looking Like "Merck 2.0" and more... |
| 2022-04-01 00:15 | | FDA says IT modernization came at right time for COVID and more... |
